FINWIRES · TerminalLIVE
FINWIRES

ASX:SIG

7 stories mentioning ASX:SIGUpdated 20d ago

Every FINWIRES story that references ASX:SIG, newest first.

Asia

ASX Midday Sector Update: Materials Stocks Rise, Health Care Struggles

Materials stocks advanced 2.3% to lead gainers in midday trading Friday as markets digested reports of renewed clashes in the Middle East.BHP Group (ASX:BHP) shares rose nearly 3%, and Rio Tinto (ASX:RIO) climbed past 3%.On the flip side, health care stocks fell 1.6% to lead decliners.Sigma Healthcare (ASX:SIG) was 2% lower after it said on Thursday that shareholders Jack and Sam Gance may sell up to 20% of their respective stakes in the company once the shares are released from escrow.

ASX 200ASX:BHPASX:RIOASX:SIG
Asia

Sigma Healthcare Says Gance Brothers to Potentially Sell Up to 20% of Their Stakes in Company

Sigma Healthcare (ASX:SIG) shareholders Jack and Sam Gance, the brothers who helped found Chemist Warehouse, remain committed to the company and have no plans to sell more than 20% of their respective stakes once the shares are released from escrow, according to a Thursday filing with the Australian bourse.The company said about 2.72 billion Sigma Healthcare shares held by the Gance brothers will be released from voluntary escrow at the close of trading on Aug. 27.Another roughly 2.3 billion shares held by Mario Verrocchi, another founder of Chemist Warehouse, will also be released on the same date, but Verrocchi does not plan to sell any of his shares in the near term, per the filing.

ASX:SIG
Asia

Update: Sigma Healthcare Withdraws From UK Drugstore Chain Sale Process; Shares Up 8%

(Updates to add stock movement in the headline and the last paragraph)Sigma Healthcare (ASX:SIG) decided to withdraw its interest from and halt discussions regarding the acquisition of UK drugstore chain Boots Group, according to a Monday filing with the Australian bourse.Following a preliminary review, the company concluded that the acquisition would not currently meet its strategic and capital investment objectives in advancing its UK expansion, the filing said.The company's shares rose 8% in recent Monday trade.

ASX:SIG
Asia

Sigma Healthcare Withdraws From UK Drugstore Chain Sale Process

Sigma Healthcare (ASX:SIG) decided to withdraw its interest from and halt discussions regarding the acquisition of UK drugstore chain Boots Group, according to a Monday filing with the Australian bourse.Following a preliminary review, the company concluded that the acquisition would not currently meet its strategic and capital investment objectives in advancing its UK expansion, the filing said.

ASX:SIG
Asia

Sigma Healthcare Confirms Discussions to Acquire UK's Boots; Shares Down 4%

Sigma Healthcare (ASX:SIG) confirmed that it is in preliminary discussions to acquire UK health and beauty retailer and pharmacy chain Boots, according to a Wednesday Australian bourse filing.The company said there is no certainty that the talks would lead to any transaction.According to a Tuesday Financial Times report, the company is competing with the billionaire Weston family, which is also in discussions to buy Boots in a potential $10 billion deal.Sigma Healthcare's shares tumbled about 4% in recent Wednesday trade.

ASX:SIG
Asia

ASX Most Active Stocks

Here are the five most actively traded big-cap stocks on the Australian Securities Exchange on Friday.Arafura Rare Earths (ASX:ARU): 80.5 million sharesPredictive Discovery (ASX:PDI): 11.8 million sharesTelstra Group (ASX:TLS): 9.2 million sharesSantos (ASX:STO): 8.2 million sharesSigma Healthcare (ASX:SIG): 7.2 million shares

ASX 200ASX:ARUASX:PDIASX:SIGASX:STOASX:TLS
Asia

Sigma Healthcare Says Chemist Warehouse Brand to Enter UK Under Agreement With Pharmacy Group; Shares Rise 4%

Sigma Healthcare (ASX:SIG) said Tuesday signed a memorandum of understanding with Greenlight Healthcare, under which the Chemist Warehouse brand will enter the UK market.The company said in a statement that it will acquire a 75% interest in a number of stores of the employee-owned pharmacy group, with 25% continuing to be held by GreenLight.Sigma will license the Chemist Warehouse brand and intellectual property, and provide retail support, while GreenLight will provide the dispensary and professional services requirements as well as back office support.The first phase of the joint venture will focus on rebranding and developing up to five stores initially, with the first site to be in Hoxton Street, northeast of the city of London. If the first phase proves to be successful, more stores could be developed in the second phase. The parties plan to identify existing GreenLight pharmacies and where appropriate develop or relocate these into Chemist Warehouse stores.Sigma Healthcare's shares rose nearly 4% in recent trading on Tuesday.

ASX:SIG

Track with the FINWIRES app suite

FolioX
FolioX
Track ASX:SIG in your portfolio
WheelAI
WheelAI
Analyze ASX:SIG options with the wheel strategy
StockInsider
StockInsider
See market sentiment on ASX:SIG